|
|
 |
|
- 1995: Current management took over and started manufacturing of Pharma Intermediates.
- 1997: Started manufacturing API's -launched its first drug Trimetazidine di hydrochloride (Cardiovascular drug)
- 2000: Came with Public offering of 25% Shares. Issue was oversubscribed by 3.85 times. Set up a R&D Block to carry out Process synthesis for API's & Intermediates.
- 2005:Hon. Finance Minister of India Shri. P Chidambaram put our company on the INDO NEXT at The Bombay Stock Exchange. Company was awarded with ISO 9001-2000 accreditation by BVQI - UKAS & BVQI - ANAB.
- 2006:Construction of a State of Art Formulation Unit for Oral Solid Dosages started. Estimated Cost of Project over 8 m USD.
- 2007:Commissioning of first formulation Plant for Tablets and Capsules at Dehradun
|
|
 |
|
